BiomX Inc. (PHGE)Healthcare | Biotechnology | Dover, United States | NYSE American
1.84 USD
-0.13
(-6.599%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.83 -0.01 (-0.010%) ⇩ (April 17, 2026, 7:56 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 4:01 p.m. EDT
PHGE is a highly volatile stock with negative fundamentals and a poor price trajectory. The recent price history shows a significant decline, and the stock is currently trading near its 52-week low. The stock's fundamentals are weak, with negative earnings and a low market cap. The stock has no dividend history, and the forecasting model indicates a low probability of a positive price movement in the short term. Investors should avoid this stock unless they are looking for a high-risk, high-reward opportunity. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.572756 |
| MSTL | 0.577395 |
| AutoARIMA | 1.264602 |
| AutoTheta | 1.297074 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.38 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.388 |
| Excess Kurtosis | -0.58 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 16,130,390 |
| Forward P/E | -0.14 |
| Beta | 1.70 |
| Website | https://www.biomx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.81010216 |
| Address1 | 850 New Burton Road |
| Address2 | Suite 201 |
| All Time High | 2,261.0 |
| All Time Low | 1.5 |
| Ask | 1.84 |
| Ask Size | 100 |
| Average Daily Volume10 Day | 262,970 |
| Average Daily Volume3 Month | 1,057,375 |
| Average Volume | 1,057,375 |
| Average Volume10Days | 262,970 |
| Beta | 1.702 |
| Bid | 1.82 |
| Bid Size | 100 |
| Book Value | -12.499 |
| City | Dover |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.84 |
| Current Ratio | 0.874 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.9 |
| Day Low | 1.7 |
| Display Name | BiomX |
| Earnings Call Timestamp End | 1,755,086,400 |
| Earnings Call Timestamp Start | 1,755,086,400 |
| Earnings Timestamp End | 1,778,785,200 |
| Earnings Timestamp Start | 1,778,785,200 |
| Ebitda | -27,998,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.665 |
| Enterprise Value | 18,625,414 |
| Eps Current Year | -5.85 |
| Eps Forward | -12.98 |
| Eps Trailing Twelve Months | -37.05 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.73768 |
| Fifty Day Average Change | -2.8976798 |
| Fifty Day Average Change Percent | -0.61162424 |
| Fifty Two Week Change Percent | -81.010216 |
| Fifty Two Week High | 14.706 |
| Fifty Two Week High Change | -12.866 |
| Fifty Two Week High Change Percent | -0.87488097 |
| Fifty Two Week Low | 1.5 |
| Fifty Two Week Low Change | 0.34000003 |
| Fifty Two Week Low Change Percent | 0.22666669 |
| Fifty Two Week Range | 1.5 - 14.706 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,552,483,800,000 |
| Float Shares | 1,121,250 |
| Forward Eps | -12.98 |
| Forward P E | -0.14175655 |
| Free Cashflow | -14,071,500 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 20 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.35863 |
| Held Percent Institutions | 0.04092 |
| Implied Shares Outstanding | 8,766,516 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,764,028,800 |
| Last Split Factor | 1:19 |
| Long Business Summary | BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company's phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from which single optimal phages are personally matched to treat specific patients. It develops BX011, a fixed multi-phage cocktail, which is in Phase 2a trial for the treatment of diabetic foot infections; and BX211, a phage therapy, which is in Phase 2 trial for the treatment of diabetic foot osteomyelitis. BiomX Inc. was founded in 2015 and is based in Dover, Delaware. |
| Long Name | BiomX Inc. |
| Market | us_market |
| Market Cap | 16,130,390 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_430935769 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -36,199,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 16,130,389 |
| Number Of Analyst Opinions | 1 |
| Open | 1.92 |
| Operating Cashflow | -26,390,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Post Market Change | -0.010100007 |
| Post Market Change Percent | -0.5489134 |
| Post Market Price | 1.8299 |
| Post Market Time | 1,776,470,207 |
| Previous Close | 1.97 |
| Price Eps Current Year | -0.31452993 |
| Price Hint | 4 |
| Price To Book | -0.14721179 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.701 |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.13 |
| Regular Market Change Percent | -6.59898 |
| Regular Market Day High | 1.9 |
| Regular Market Day Low | 1.7 |
| Regular Market Day Range | 1.7 - 1.9 |
| Regular Market Open | 1.92 |
| Regular Market Previous Close | 1.97 |
| Regular Market Price | 1.84 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 180,718 |
| Return On Assets | -0.78852 |
| Return On Equity | -3.1689599 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 8,766,516 |
| Shares Percent Shares Out | 0.013099999 |
| Shares Short | 86,010 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 96,310 |
| Short Name | BiomX Inc. |
| Short Percent Of Float | 0.013099999 |
| Short Ratio | 1.04 |
| Source Interval | 15 |
| State | DE |
| Symbol | PHGE |
| Target High Price | 304.0 |
| Target Low Price | 304.0 |
| Target Mean Price | 304.0 |
| Target Median Price | 304.0 |
| Total Cash | 4,360,000 |
| Total Cash Per Share | 2.736 |
| Total Debt | 1,436,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -37.05 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.69727 |
| Two Hundred Day Average Change | -4.85727 |
| Two Hundred Day Average Change Percent | -0.72526115 |
| Type Disp | Equity |
| Volume | 180,718 |
| Website | https://www.biomx.com |
| Zip | 19,904 |